Curative Biotechnology (CUBT) Financial Statements
Curative Biotechnology Financial Overview
Curative Biotechnology's market cap is currently $4.43M. The company's EPS TTM is $-0.41; its P/E ratio is -1.60; Curative Biotechnology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -87.84K | $ -92.21K | $ -97.52K | $ -7.96K | $ -6.74K |
| Operating Income | $ -1.50M | $ -2.44M | $ -1.93M | $ -4.47M | $ -5.01M |
| EBITDA | $ -1.41M | $ -2.35M | $ -2.50M | $ -4.36M | $ -5.16M |
| Net Income | $ -2.26M | $ -3.56M | $ -3.96M | $ -5.38M | $ -5.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 45.04K | $ 19.53K | $ 56.40K | $ 58.67K | $ 670.26K |
| Total Assets | $ 2.11M | $ 2.16M | $ 2.60M | $ 2.09M | $ 2.41M |
| Total Debt | $ 1.36M | $ 1.37M | $ 2.26M | $ 1.07M | $ 0.00 |
| Net Debt | $ 1.31M | $ 1.35M | $ 2.20M | $ 1.01M | $ -670.26K |
| Total Liabilities | $ 8.20M | $ 7.08M | $ 5.75M | $ 22.62M | $ 18.77M |
| Stockholders' Equity | $ -6.09M | $ -4.91M | $ -3.14M | $ -2.54M | $ 1.68M |
| Cash Flow | |||||
| Free Cash Flow | $ -868.87K | $ -1.02M | $ -500.63K | $ -1.61M | $ -1.63M |
| Operating Cash Flow | $ -868.87K | $ -1.02M | $ -486.58K | $ -1.54M | $ -1.60M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ -14.04K | $ -76.91K | $ -21.33K |
| Financing Cash Flow | $ 894.38K | $ 985.88K | $ 498.36K | $ 1.00M | $ 2.14M |
Currency in USD